Skip to main content
Tech.euFundingExplorerBeta

Engitix

Human extracellular matrix (ECM) drug target discovery platform.

Total raised
€69M
€69,049,941
Funding rounds
2
Investors
3
distinct backers
Active since
2022-01
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD

Signals

High confidence
Raise-next likelihood26
base rate 44% for Series A
  • Raised very recently
  • Down/flat last round
Exit likelihood14
base rate 12% (2+ rounds)
  • €30M+ raised

Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-01-08Series A€21MMike Platt,Netherton InvestmentsView deal →
2022-01-19Series A€48MDompé,Netherton InvestmentsView deal →

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €5.0B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B